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Mineralocorticoid—stimulated renal acidification: The critical role of
dietary sodium. Recent in vitro studies of isolated distal nephron
segments have demonstrated that 1) mineralocorticoid hormone stimu-
lates H secretion by both Nat-dependent and Nat-independent
mechanisms, and 2) the Nat-independent acidification mechanism has
a greater capacity. These in vitro data suggest that mineralocorticoid
administration in viva might increase renal acid excretion when an
augmentation in distal Na reabsorption is precluded by rigid restric-
tion of dietary Nat; under these circumstances, virtually all Na
delivered to the distal nephron is reabsorbed in the basal state. In the
present studies, prolonged (12 days) administration of DOC (15 mg/day)
was undertaken in both Nat-fed and rigidly Na-restricted dogs with
chronic HCt acidosis. Nat-fed animals responded to DOC administra-
tion with a large increment in net acid excretion and complete correc-
tion of metabolic acidosis. Marked hypokalemia and significant
kaliuresis also occurred. Nat-restricted dogs experienced no changes
in renal acid excretion, systemic acid—base equilibrium, plasma IKJ or
Kt balance. These results suggest that both renal Ht and K excre-
tory responses to prolonged mineralocorticoid hormone administration
in vivo are critically dependent on the availability for reabsorption of
surplus Nat within the distal nephron; this requirement is met when the
diet, and hence the final urine, contains Na but cannot be satisfied
when dietary Nat is rigidly restricted.
Chronic administration of supraphysiologie amounts of mm-
eralocorticoid hormone to animals fed a normal sodium diet
results in transient sodium retention and a persistent stimula-
tion of distal hydrogen ion secretion; as a result, renal net acid
excretion increases transiently, new bicarbonate is generated
and renal bicarbonate reabsorption increases [1-41.
Recent in vitro studies of isolated perfused distal nephron
segments have suggested that there are at least two major
mechanisms whereby mineralocorticoid hormone can stimulate
renal acidification. First, mineralocorticoid hormone can aug-
ment the rate of sodium—dependent hydrogen ion secretion in
rabbit cortical collecting tubules by enhancing the lumen—nega-
tive potential difference [5—71. Second, mineralocorticoid hor-
mone can augment the rate of sodium—independent hydrogen
ion secretion by stimulating an active, electrogenie transport
process in rabbit cortical collecting tubule and outer medullary
collecting duct (MCD) [5, 8]. Stone et al concluded that the
Received for publication February 4, 1985,
and in revised form July 19, 1985
© 1986 by the International Society of Nephrology
MCD has "the capacity for aldosterone—regulated acidification
through a mechanism which is autonomous of sodium delivery
or reabsorption" [8]. There is evidence that the capacity of the
sodium—independent medullary mechanism greatly exceeds
that of the sodium—dependent cortical process [5, 8, 91. The
existence in the isolated turtle urinary bladder of a sodium—
independent acidification mechanism that is stimulated by
aldosterone also is well recognized [10].
These in vitro findings suggest that mineralocorticoids might
stimulate renal acidification in vivo even in animals deprived of
dietary sodium. Such animals would lack the capacity to in-
crease distal sodium reabsorption because all sodium delivered
to the distal nephron would be fully reabsorbed in the basal
state. This constraint should, however, pose no obstacle to the
sodium—independent acidification mechanism.
Thus, the question was posed: can mineralocorticoids stim-
ulate renal acidification importantly in the absence of dietary
sodium. Fragmentary data from studies performed in the 1950's
suggest not; DOC administered to three subjects ingesting a
sodium—restricted diet induced negligible changes in urinary
acid—base composition [3]. In view of the potential significance
of the recent in vitro data, however, we thought a more rigorous
examination of the issue was clearly warranted. We chose to
assess the importance of the sodium—independent, mineralo-
corticoid—responsive acidification mechanism in the intact or-
ganism by comparing the effect of chronic mineralocorticoid
administration in aeidotic dogs receiving no dietary sodium to
that observed in animals ingesting ample sodium. We chose to
examine acidotic rather than normal animals in order to maxi-
mize the likelihood of detecting a difference in the steady—state
increment in plasma bicarbonate induced by mineralocor-
ticoids. As shown previously in studies of animals ingesting a
sodium—rich diet, when daily endogenous acid load is normal,
the mineralocorticoid—induced increment in net acid excretion
is sufficient to generate only a small surplus of extracellular
bicarbonate, which is sustained by the augmented tubular
acidification. In contrast, when the daily acid load is increased
by the chronic administration of hydrochloric acid, the aug-
mented tubular acidification induced by mineralocortieoid hor-
mone is sufficient to return the frankly depressed plasma
bicarbonate to normal and to maintain it there in the presence of
continued ingestion of the hydrochloric acid load [2].
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Methods
Studies on the effect of sodium intake on mineralocorticoid
hormone—induced changes in acid—base equilibrium were car-
ried out in 13 female mongrel dogs weighing between 10 and 21
kg. Animals were utilized for study only if average control
plasma—bicarbonate concentration was between 19.0 and 24.0
mEq/liter. Throughout the study each dog was fed 30 g/kg/day
of a synthetic diet, the composition of which has been previ-
ously described Fill. The intrinsic electrolyte content of the diet
was less than 1.0 mEq of sodium, 0.3 mEq of chloride and 0.1
mEq of potassium per 100 g. All animals received 2.5
mEq/kg/day of potassium as neutral phosphate. Mineralocor-
ticoid hormone was administered as DOC acetate in oil
(Organon, West Orange, New Jersey), 7.5 mg intramuscularly
twice a day. The sodium content of the diet was determined by
the requirements of the individual protocols, as noted below.
Supplemental electrolytes were added to the homogenized diet
from stock solutions, the compositions of which were verified
by direct analyses. The diet was homogenized with twice its
weight of water and fed in one or two portions. Dogs that did
not eat spontaneously were tube—fed and those that vomited at
any time were not included.
Fasting arterial blood samples were drawn percutaneously
from the femoral artery (9 am.) in heparinized glass syringes at
24 to 72 hr intervals. Urine was collected in metabolic cages
over stainless steel surfaces into glass bottles containing min-
eral oil and thymol-chloroform preservative. Values for urinary
excretion and balance data are reported as normalized to 20 kg
body wt.
Group I: DOC administration to dogs with HCI-induced
chronic metabolic acidosis receiving a normal sodium diet
(N = 6). Following a stable control period of four to eight days
duration, HC1 7.0 mmole/kg was added to the daily diet for a 10
to 12 day period, an interval more than sufficient to produce a
steady—state of metabolic acidosis [12]. DOC was administered
for an additional 12 day period during continued HCI adminis-
tration. NaCI, 2.5 mmole/kg, was added to the daily diet during
all periods of study.
Group II: DOC administration to dogs with HC1-induced
chronic metabolic acidosis receiving a sodium-restricted diet
(N = 7). The protocol for this group was identical to that of
Group I except that no NaCl was added to the diet.
The details of the balance technique, calculations and analyt-
ical methods have been described previously [13, 14]. Urinary
net acid is calculated as ammonium plus titratable acidity minus
bicarbonate. The anion gap in plasma is calculated as (Nat +
K) — (Cl— + HC03) mEq/liter. Statistical significance was
determined by Student's I-test [151.
Results
Group I
HC1 feeding resulted in the anticipated steady—state of
hyperchloremic acidosis (Fig. I, Table 1). Administration of
DOC resulted in significant changes in renal excretion and in
systemic acid—base and electrolyte composition. Plasma bicar-
bonate concentration increased significantly and blood hydro-
gen ion concentration decreased significantly; indeed, complete
correction of metabolic acidosis occurred. The correction of
acidosis was attributable to a large cumulative increment in
urinary net acid excretion (+ 180 mEq, P < 0.05), accounted for
largely by a cumulative increment in ammonium excretion
44 Harrington Ct al
Plasma
[HCO]
mEqiliter 52
48
44
40
Plasma[KJ
mEq//iter
Urine
pH
Urine +160ANH
excretion + 80
mEq/24hr 0
—80
Urine +160
A net acid + 80
excretion 0
mEq/24hr
1.1 —80
Urine +30AK 0
excretion -- 30
mEq/24hr
I.)
Blood[H]
nEq/Iiter
(0)
A NH
Excretion
mEq('I
.A Net acid
Excretion
mEq
A K
Excretion
mEq
—6 4 -2 0 2 4 6 8 10 12
Time, days
Fig. 1. Effect of DOC administration on
plasma bicarbonate, hydrogen ion, and potas-
sium concentrations, urine pH, and changes
in urine ammoniu,n, net acid, and potassium
excretion in acidotic animals receiving a nor-
mal sodium intake (Group I). Cumulative
changes (A) in urine acid and potassium ex-
cretion also are depicted. Data are plotted as
mean SEM (N = 6).
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Table 1. Effect of dietary Na intake on steady—state changes in plasma composition and body weight in response to DOC administration
during chronic HCI acidosis (means SEM)
Ha PaCO2
Period nEq/liter mm Hg
HCO
,nEq/ljter
HCO3
inEqiliter
Anion
Gap
mEq/liter
C1
,nEq/liter
Na
,nEq/liter
K
rnEq/liter
Creatinine
mg/IOU ml
Weight
kg
Group I, normal Na diet (N = 6)
Control 40.7 36
HCI 51.7" 31"
Final 7 days
HClandDOC 42.0" 36'
Days 8—12
Group II, Na restricted diet (N 7)
21.6
14.3"
20.7"
22.4
15.0"'
15.6"
—7.3"
6.4w'
—7.3
0.6"
18
15*
16
18
17*
l4*
109
ll8t
113"
107"
116
117"
145
144'
148
144
144
143
3.7
3.0"
2.2'
3.8
3315
3.3
0.65
0.68
0.67
0.64
0.54*5
0.52
15.3
15.3
15.4
1l.6
11.5
ll.5
Control 39.6 37
HCI 50.9
Final7 days
HCIandDOC 51.7" 33*
Days 8—12
Abbreviations are: H,, hydrogen ion activity in arterial blood; PaCO2, CO2 tension in arterial blood. ', "and significantly different from the
previous period at the 0.05, 0.01, and 0.001 probability levels, respectively; ", and : significantly different from Group I at the 0.05, 0.01, and
0.001 probability levels, respectively.
Plasma
[HCO ]
rnEq/Iiter
Plasma
[K I
mEq/Iiter
Urine
pH
Urine
NH
Excretion
mEq/24hr
I.)Urine
X net acid
excretion
mEq/24hr
1.1
Urine
excretion
mEq/24hr
(a)
NH
Excretion
mEq
I.)
Net acid
excretion
mEq
K
Excretion
mEq
(+ 168 mEq, P < 0.05). Plasma potassium concentration de-
creased significantly during DOC administration and WaS ac-
companied by a significant ctimulative increment in renal po-
tassium excretion (+58 mEq, P < 0.05). A significant positive
sodium balance (cumulative balance, day 12 of DOC, +134
mEq, P < 0.01) was observed but no significant change in
chloride balance occurred. The corresponding changes in p0-
tassium and nitrogen—corrected potassium balances were 77
mEq (P < 0.05) and —96 mEq (P 0.01), respectively.
Group II
HCI feeding resulted in a level of hyperchloremic acidosis
that was not significantly different from that observed in the
Group I animals fed a normal sodium diet (Fig. 2). In contrast to
the Group I animals, however, DOC administration caused no
significant changes in plasma bicarbonate, potassium or hydro-
gen ion concentration and did not alter urinary acid—base or
electrolyte composition (Fig. 2, 'fables 1 and 2).
Discussion
Several lines of evidence might lead one to predict that the
stimulatory effect of mineralocorticoids on renal acid excretion
in the intact animal would occur even in the absence of dietary
sodium. First, chronic administration of DOC and a normal
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Fig, 2. Effect of DOC administration on
plasma bicarbonate, hydrogen ion, and potas-
siu,n concentrations, urine pH, and changes
in urine amrnonjum, net acid and potassium
excretion in acidotic animals receiving a
sodium—re,rtricted diet (Group II). Cumulative
changes (iA) in urine acid and potassium ex-
cretion also are depicted. Data are plotted as
mean SF.M (N = 7).
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Table 2. Effect of dietary Na intake on the steady—state renal response to DOC administration during chronic HCI acidosis (means SEM)
Pi
NH4 T.A. HC03 Net Acid mmole/24 Na K Cl Volume
Period pH mEq/24 hr mEq/24 hr mEq/24 hr mEq/24 hr hr mEqI24 hr mEqI24 hr mEq/24 hr ml/24 hr
Group 1, normal Na diet (N = 6)
29 1.8 70 44 37 47 44 936Control 5.98 43
±0.06 ±1.9 ±1.2 ±0.4 ±2.8 ±1.4 ±2.5 ±1.4 ±2.0 ±25
HCI
Final7 days 5.35' 150" 32* 0.1* 182* 42 44 46 166* 955
±0.02 ±3.2 ±0.6 ±0.0 ±3.6 ±0.8 ±1.8 ±1.1 ±3.6 ±24(Day 12, ) (+960) (+46) (—16) (+l023) (—14) (+90*) (+44*) (+l2l9)
±42 ±20 ±8 ±67 ±13 ±26 ±16 ±39
HCI and DOC
Days 8—12 5.50* l66 33 0.2" 199* 43 34* 50 170 961
±0.03 ±5.3 ±1.2 ±0.0 ±6.4 ±1.6 ±2.6 ±2.0 ±6.0 ±38
(Day 12, 4) (+168*) (+12) (+1") (+180*) (+9) (_l16*) (+58*) (+62)
±45 ±11 ±0 ±49 ±13 ±31 ±21 ±44
Group II, Na restricted diet (N = 7)
31 0.9 75 45 2 44 l925 Control5.90 45
±0.03 ±2.6 ±1.5 ±0.1 ±3.9 ±2.0 ±0.6 ±2.1 ±0.4 ±47
HCI
Final7 days 544*5 163*5 30*5 0.2*r j93*5 40* 3 43 l28* 924
±0.01 ±3.7 ±0.8 ±0.0 ±4.3 ±1.0 ±0.4 ±1.8 ±3.1 ±25
(Day 12, (+1041*) (—5) (7*) (+1043) (—52) (+95) (+11) (+l149)
±40 ±20 ±2 ±52 ±20 ±13 ±49 ±19
HCI and DOC
Days 8—12 5.45 159 31 0.3 190' 41 1*1] 46 l25 936
±0.01 ±4.4 ±0.9 ±0.0 ±5.2 ±1.2 ±0.4 ±2.3 ±4.1 ±31
(Day 12, ) (—38' (+6) (+lt) (—33' (+ 12) (—14') (+11) (33)
±40 ±10 ±0 ±38 ±13 ±8 ±44 ±26
Symbols are the same as Table 1. Symbol signifies the cumulative change in excretion values (within parentheses, mEq) over the respective
12-day period and reflects the accumulated daily differences from the mean excretion value for the previous steady—state period. Values for urinary
excretion and balance data are normalized to 20 kg body wt.
sodium diet to dogs with chronic hyperchloremic metabolic
acidosis pretreated with amiloride to block sodium—dependent
distal acidification results in significant increases in both net
acid excretion and plasma bicarbonate concentration [2]. This
finding suggests that the augmentation in renal acidification
induced by mineralocorticoid hormone in vivo is largely sodium—
independent. Second, mineralocorticoid hormones cause aug-
mented renal ammoniagenesis in vitro [16]; this raises the
possibility that a direct stimulation of ammoniagenesis by
mineralocorticoid in vivo might be sufficient to increase net acid
excretion and plasma bicarbonate concentration. Third, sodium—
independent hydrogen ion secretion is known to occur both in
cortical collecting tubule [5], and in outer medullary collecting
duct [81; hydrogen ion secretion at both sites can be stimulated
by mineralocorticoids.
The results of the present study stand in sharp contrast to the
prediction derived from these lines of evidence. Mineralocor-
ticoids administered in large doses to acidotic, sodium—
restricted dogs (Group II) caused no detectable change in net
acid excretion or plasma bicarbonate concentration. These
observations imply that the sodium—independent mineralocorti-
coid—responsive hydrogen ion transport systems clearly identi-
fied in vitro are not able to make a sufficiently large contribution
to overall tubular acidification in vivo to influence importantly
extracellular or even urinary composition under these circum-
stances) Moreover, these data underscore the hazards of
predicting the integrated response of functioning nephron units
or of the entire kidney from quantitative assessments of trans-
port phenomena in certain tubular segments. Thus, finding that
segments of cortical and medullary collecting ducts manifest a
large capacity for sodium—independent hydrogen ion transport
in response to mineralocorticoids does not necessarily imply
that such transport systems contribute in a major way to the
acidification response to these hormones in the intact animal.
Alternatively, of course, one must consider the possibility that
the sodium—independent, mineralocorticoid—responsive acidifi-
cation mechanism demonstrated in the rabbit collecting tubule
simply does not exist in the dog. Such a striking species dif-
ference in mammalian nephron transport characteristics seems
to us highly improbable.
As already noted, previous studies have shown that
amiloride—treated dogs with hyperchloremic acidosis given
DOC and a normal sodium diet exhibited a significant increase
Since Stone et al did not assess the chloride dependence of the outer
medullary collecting duct acidification in response to mineralocor-
ticoids 18], it remains to be determined whether the high luminal
chloride concentration presumably achieved in the distal segment in the
present studies might mitigate in vivo the potent acidification mecha-
nism demonstrated in vitro.
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in net acid excretion and plasma bicarbonate concentration [2].
Amiloride is known to obliterate the sodium—dependent,
lumen—negative potential difference in cortical collecting tu-
bules in vitro [17, 181. Why does placing a limitation on distal
sodium reabsorption by dietary sodium restriction block
mineralocorticoid—induced urinary acidification when pharma-
cologic inhibition of distal sodium—dependent hydrogen ion
transport did not? One possibility is that insufficient amiloride
has been administered to block completely the sodium—depend-
ent process; in view of the large dose administered, this seems
unlikely. A second possibility is that mineralocorticoids stimu-
late sodium—dependent hydrogen ion secretion in tubular seg-
ments impervious to the effect of amiloride. Further studies will
be required to clarify this issue.
The present results provide no support for the thesis that the
stimulating effect of mineralocorticoid hormone on renal acid
excretion is due to a direct augmentation of renal ammonia-
genesis. Administration of aldosterone to rats ingesting a nor-
mal sodium diet resulted in significant increases in urinary
ammonium excretion and metabolic alkalosis within 12 hr of
hormone administration; renal ammoniagenesis was increased
in the absence of a change in plasma potassium concentration or
potassium balance [16]. However, the present study provides
no evidence of DOC-induced augmentation of renal ammonia-
genesis in the sodium-restricted Group II animals (Fig. 2, Table
2). If DOC administration did result in an increase in renal
ammoniagenesis in the sodium—restricted Group II dogs, the
increase was of insufficient magnitude to result in detectable
changes in either net acid excretion or systemic acid—base
equilibrium.
Could the failure of DOC administration to increase net acid
excretion in Group II, sodium—restricted dogs be due to lesser
degrees of basal hypokalemia and potassium depletion than
those prevailing in animals receiving a normal sodium intake
(Tables 1 and 2)? We believe not. Previous studies have
demonstrated that chronic DOC administration does elicit a
renal acidification response and causes plasma bicarbonate to
rise significantly in sodium—replete animals given sufficient
potassium to prevent appreciable potassium depletion [21.
However, since the DOC-indueed increment in net acid excre-
tion observed in the sodium—replete group of the present study
occurred in the company of mineralocorticoid—stimulated
kaliuresis and hypokalemia, our results cannot exclude a per-
missive role for potassium depletion in modulating the renal
acid excretory response to the hormone.
The present studies also demonstrate that the ability of
mineralocorticoids to stimulate potassium excretion in vivo, no
less than their ability to stimulate acid excretion, is dependent
on adequate sodium intake; in the absence of dietary sodium,
the administration of mineralocorticoids caused neither hypo-
kalemia nor augmented renal potassium excretion. The recent
observation that potassium secretion in the rat superficial distal
convoluted tubule is highly dependent on the magnitude of the
lumen—negative potential difference, and hence, on the rate of
sodium reabsorption is consistent with our findings [19]. That
potassium secretion in isolated perfused rabbit cortical collect-
ing tubules is also sodium—dependent has been demonstrated
recently; potassium secretion ceased when mean luminal so-
dium concentration was reduced to values below 8 to 10
mEq/litcr [20]. A major role for sodium—dependent transepithe-
hal voltage in regulating distal tubular potassium secretion,
however, has not been a universal finding [21].
In conclusion, despite the existence of sodium—independent,
mineralocorticoid—responsive hydrogen ion secretory pro-
cesses within the mammalian distal nephron, the administration
of supraphysiologie amounts of mineralocorticoids to the intact
organism appears to enhance the bulk transfer of hydrogen ion
into the urine only when a surplus of luminal sodium is available
for augmented reabsorption. This finding strongly suggests that
sodium—dependent hydrogen ion secretion, just as sodium—de-
pendent potassium secretion, is the dominant mechanism ac-
counting for the renal effects of mineralocorticoid excess on
acid—base balance in the living organism.
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